Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

GENENTECH INC

  • FDA Approval
  • March 04, 2024, 09:49 UTC
  • 36
  • 0 comments

FDA approve BALOXAVIR MARBOXIL

Comment Full text

LANTHEUS MEDCL

  • FDA Approval
  • March 04, 2024, 09:49 UTC
  • 38
  • 0 comments

FDA approve PERFLUTREN

Comment Full text

AMNEAL

  • FDA Approval
  • March 04, 2024, 09:49 UTC
  • 34
  • 0 comments

FDA approve TRANEXAMIC ACID

Comment Full text

TAKEDA PHARMS USA

  • FDA Approval
  • March 04, 2024, 09:49 UTC
  • 42
  • 0 comments

FDA approve IXAZOMIB CITRATE

Comment Full text

INVAGEN PHARMS

  • FDA Approval
  • March 04, 2024, 09:49 UTC
  • 41
  • 0 comments

FDA approve NADOLOL

Comment Full text

GENENTECH INC

  • FDA Approval
  • March 04, 2024, 09:49 UTC
  • 33
  • 0 comments

FDA approve BALOXAVIR MARBOXIL

Comment Full text

AMNEAL

  • FDA Approval
  • March 04, 2024, 09:49 UTC
  • 37
  • 0 comments

FDA approve OFLOXACIN

Comment Full text

ZYDUS PHARMS

  • FDA Approval
  • March 04, 2024, 09:49 UTC
  • 39
  • 0 comments

FDA approve ATENOLOL; CHLORTHALIDONE

Comment Full text

PFIZER

  • FDA Approval
  • Feb. 29, 2024, 14:09 UTC
  • 37
  • 0 comments

FDA approve FESOTERODINE FUMARATE

Comment Full text

KALEO INC

  • FDA Approval
  • Feb. 29, 2024, 13:50 UTC
  • 50
  • 0 comments

FDA approve EPINEPHRINE

Comment Full text
  • Previous
  • 537
  • 538
  • 539
  • 540
  • 541
  • Next

Search

News categories

  • Technical Exchange News(13116)
  • Event(6229)
  • SEC News(328517)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(183571)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin